ImmuCell Corporation (ICCC) financial statements (2021 and earlier)

Company profile

Business Address 56 EVERGREEN DR
PORTLAND, ME 04103
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,9468,7742,5213,79910,6246,0373,339
Cash and cash equivalents6,9506,2932,5213,7995,1501,573850
Short-term investments9962,481  5,4744,4642,489
Receivables1,8481,6379491,3589967541,024
Inventory, net of allowances, customer advances and progress billings2,0932,5182,3322,0502,127870946
Inventory2,0932,5182,3322,0502,127870946
Prepaid expense253218143131127183133
Other undisclosed current assets17414771704752827
Total current assets:12,15713,1896,4217,50714,3487,8735,469
Noncurrent Assets
Operating lease, right-of-use asset1,220 
Property, plant and equipment26,75525,26626,02826,0709,8465,7193,838
Long-term investments and receivables     487496
Long-term investments     487496
Intangible assets, net (including goodwill)191210229248267  
Goodwill9696969696  
Intangible assets, net (excluding goodwill)96115134153172  
Derivative instruments and hedges  40    
Other noncurrent assets2627131345019
Other undisclosed noncurrent assets   4732014721,230
Total noncurrent assets:28,19325,50326,31026,79210,3496,7275,583
TOTAL ASSETS:40,35038,69232,73134,29924,69714,60111,052
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,3501,2211,2211,7231,892662852
Accounts payable6025726041,2221,507201456
Accrued liabilities851519364835642
Employee-related liabilities525400358255200243145
Other undisclosed accounts payable and accrued liabilities13798165182102162208
Debt760   133136150
Deferred compensation liability     20 
Deferred revenue and credits2434 7
Other undisclosed current liabilities1011,2751,344317   
Total current liabilities:2,2112,4952,5652,0642,0598181,009
Noncurrent Liabilities
Long-term debt and lease obligation9,8727,1478,4218,6392,8793,091746
Long-term debt, excluding current maturities8,7377,1478,4218,6392,8793,091746
Operating lease, liability1,135 
Liabilities, other than long-term debt 59     
Derivative instruments and hedges, liabilities 59     
Other undisclosed noncurrent liabilities(1,135)  1377939
Total noncurrent liabilities:9,8727,2058,4218,6402,9163,169785
Total liabilities:12,0839,70110,98610,7044,9753,9871,793
Stockholders' equity
Stockholders' equity attributable to parent28,26628,99121,74423,59519,72210,6149,258
Common stock730730566566504326326
Treasury stock, value(175)(188)(205)(408)(432)(451)(512)
Additional paid in capital31,37231,13222,69622,45818,52610,15010,042
Accumulated other comprehensive income (loss) (44)30(1)(24)(50)(23)
Retained earnings (accumulated deficit)(3,660)(2,638)(1,343)9791,147639(575)
Total stockholders' equity:28,26628,99121,74423,59519,72210,6149,258
TOTAL LIABILITIES AND EQUITY:40,35038,69232,73134,29924,69714,60111,052

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues15,34213,72310,98610,4319,54410,2298,023
Revenue, net10,4319,54410,2298,023
Cost of revenue
(Cost of Goods and Services Sold)
(8,479)(6,983)(5,792)(5,210)(4,123)(3,978)(3,148)
Other undisclosed gross profit      (426)
Gross profit:6,8636,7405,1945,2215,4216,2514,449
Operating expenses(8,243)(7,694)(6,640)(5,464)(4,530)(4,129)(4,655)
Operating income (loss):(1,380)(954)(1,447)(243)8902,122(206)
Nonoperating income (expense)348(314)(413)(196)(132)(6)(49)
Investment income, nonoperating     (6)(4)
Other nonoperating income (expense)348(314)(413)(196)(132) (49)
Interest and debt expense(8)(432)(428)(219)(162)(80)(58)
Income (loss) from continuing operations before equity method investments, income taxes:(1,040)(1,699)(2,288)(657)5972,036(313)
Other undisclosed income from continuing operations before income taxes84324282191622758
Income (loss) from continuing operations before income taxes:(1,032)(1,267)(1,860)(438)7582,064(255)
Income tax expense (benefit)10(28)(462)270(250)(850)88
Net income (loss) available to common stockholders, diluted:(1,022)(1,296)(2,322)(168)5081,213(167)

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(1,022)(1,296)(2,322)(168)5081,213(167)
Other comprehensive income (loss)44(74)312326(27)(3)
Comprehensive income (loss), net of tax, attributable to parent:(978)(1,370)(2,291)(145)5351,186(171)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: